CCM
VIVO

Century Capital Management’s Meridian Bioscience Inc VIVO Stock Holding History

Century Capital Management’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-577,611
Closed -$12.4M – 173
2013
Q2 		$12.4M Buy
+577,611
New +$12.5M 0.49% 92

Other funds holding VIVO

BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
CPCM
Clifton Park Capital Management Wilmington, Delaware $881M AUM 5.59% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Century Capital Management's VIVO Position: Q3 2013 in Review

Century Capital Management sold out of Meridian Bioscience Inc (VIVO) in Q3 2013, closing a stake of 577,611 shares — an estimated $12.4M sold.

Century Capital Management first reported a position in VIVO in Q2 2013 and held it in 1 quarter. The position peaked at $12.4M in Q2 2013. 166 funds tracked by Wall St. Rank hold VIVO as of Q3 2013.

  • Century Capital Management reported no remaining Meridian Bioscience Inc position as of Q3 2013 after selling out during the quarter.
  • Century Capital Management sold 577,611 Meridian Bioscience Inc shares in Q3 2013, an estimated $12.4M.
  • Century Capital Management first reported a position in Meridian Bioscience Inc in Q2 2013 and held it in 1 quarter.
  • Century Capital Management's Meridian Bioscience Inc position peaked at $12.4M in Q2 2013.
  • 166 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2013.

Based on Century Capital Management's 13F filing for Q3 2013, filed 12 Nov 2013.